The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global drug-device combination market is poised for remarkable growth, projected to increase from $108.43 billion in 2022 to $121.17 billion in 2023, showcasing a robust compound annual growth rate (CAGR) of 11.75%. Looking ahead, this market is expected to reach $179.10 billion in 2027 at a CAGR of 10.26%. Fueling this expansion is the escalating prevalence of chronic diseases, pushing the boundaries of therapeutic and diagnostic innovations.

Chronic Diseases on the Rise

The surging prevalence of chronic diseases is a primary driver behind the growth of the drug-device combination market. Chronic diseases, including heart disease and diabetes, persist for extended periods, often requiring ongoing medical care. In 2022, diabetes alone affected more than 420 million individuals globally, as reported by the World Health Organization. Projections indicate that by 2030 and 2045, these numbers will surge to 578 million and 700 million, respectively. This alarming rise in chronic diseases underscores the urgent need for effective treatment modalities, positioning drug-device combinations at the forefront.

• Global Diabetes Statistics (2022):
  • Affected individuals: 420 million
  • Projected increase by 2030: 578 million
  • Projected increase by 2045: 700 million

Key Market Players

Major players are shaping the trajectory of the drug device combination market, contributing to its growth and evolution. Leading corporations, including The 3M Company, Abbott Laboratories, and Medtronic PLC., are pivotal in advancing the field of therapeutic and diagnostic combinations.

• Major Market Players:
  • The 3M Company
  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • R. Bard Inc.
  • Medtronic PLC.
  • Amgen Inc.
  • Ypsomed
  • Micron Biomedical Inc.
  • MetP Pharma AG
  • Sonceboz
  • Propeller Health B.D.
  • Lepu Medical Technology
  • Eitan Medical Ltd.
  • Vaxess Technologies Inc.
  • Subcuject Aps.

Technological Advancements

Technological innovation is a defining trend in the dynamic landscape of the drug-device combination market. Major corporations are spearheading the introduction of new technologies, as exemplified by Owen Mumford’s Aidaptus auto-injector platform. Launched in September 2021, Aidaptus is a two-stage, spring-powered auto-injector featuring self-adjusting plunger stopper sensing technology. This innovative platform adjusts automatically to various stopper positions and fills levels in each syringe without the need for additional parts, showcasing the industry’s commitment to advancing drug-device combinations.

Market Segmentation

Understanding the diverse segments within the drug-device combination market is crucial for stakeholders to navigate this rapidly evolving landscape effectively.

1. By Product:
   • Auto-Injector
   • Microneedle Patch
   • Digital Pill
   • Smart Inhaler
   • Drug Delivery Hydrogels
   • Drug-Eluting Lens
   • Other Products
2. By Application:
   • Orthopedic Diseases
   • Respiratory Diseases
   • Diabetes
   • Oncology
   • Cardiovascular Diseases
   • Other Applications
3. By End User:
   • Clinics
   • Hospitals
   • Home Care Settings
   • Ambulatory Care Centers
   • Other End Users
4. By Distribution Channel:
   • Direct Tender
   • Retail Sales
   • Other Distribution Channels

Regional Dynamics

Geographical variations play a pivotal role in the distribution and growth of the drug-device combination market. In 2022, North America emerged as the largest region in terms of market share. Looking forward, Asia-Pacific is expected to be the fastest-growing region, highlighting the global nature of advancements in therapeutic and diagnostic combinations.

View More On The Drug Device Combination Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Request A Sample Of The Global Drug Device Combination Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8206&type=smp

The Drug Device Combination Global Market Report 2023  provides a comprehensive overview on the drug device combination market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Acne Drugs Global Market Report 2023
Hypolipidemics Global Market Report 2023
Antivirals Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model